IRB Advisor – June 1, 2019
June 1, 2019
View Issues
-
A Half-Century Later, Guatemala Experiments Still Horrify
Bioethicists recently published a case study of this horrific chapter in human research history after comprehensively reviewing all the records of the Guatemala experiments. The most egregious aspect was that some participants were intentionally infected with syphilis and other STDs.
-
Electronic Informed Consent Platform Enhances Education and Engagement
Since Memorial Sloan Kettering Cancer Center implemented the electronic informed consent process, thousands of research participants have consented electronically, increasing at a rate of about 500 per month.
-
Should IRBs Set an Incentive Pay Limit?
Not all IRBs and research institutions specifically address limits to how much researchers can compensate study participants. But allowing these limits to default to what is reportable to the IRS as income could be a mistake, one IRB chair says.
-
Diverse Populations Joining NIH All of Us
Nearly a quarter of a million people have joined the National Institutes of Health’s ambitious All of Us precision medicine initiative — with a large response from racial and ethnic minorities who have been historically victimized or ignored by human research.
-
Next Challenge for IRBs: Nanomedicine Research Risks
IRB members soon will see — if they haven’t already — protocols involving medical therapies with materials that are so tiny that a human hair is 80,000 times their width.
-
New Tool Helps With Study Recruitment
Department of Energy researchers developed a new tool to connect cancer patients with clinical trials. The tool uses a Netflix-style of analytics to recommend studies that would be a good fit for particular patients.